Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,441.05INR
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
Rs2,441.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,071
52-wk High
Rs2,798.50
52-wk Low
Rs2,201.20

Revenue & Earnings Per Share

 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-17 1 7,292.00 7,292.00 7,292.00 --
Quarter Ending Mar-18 1 10,413.00 10,413.00 10,413.00 --
Year Ending Mar-17 9 29,429.40 31,443.30 28,000.00 --
Year Ending Mar-18 9 31,860.60 33,893.00 29,680.00 35,059.80
Year Ending Mar-19 9 35,858.90 39,101.00 33,240.00 37,297.80
Earnings (per share)
Year Ending Mar-17 8 38.34 49.50 32.00 --
Year Ending Mar-18 9 42.61 46.00 37.49 64.72
Year Ending Mar-19 9 52.17 63.40 40.29 54.62
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 62.45 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta 0.17 0.90 0.88
Price to Sales (TTM) 14.01 3.93 5.40
Price to Book (MRQ) -- 4.81 5.38
Price to Tangible Book (MRQ) -- 5.53 6.78
Price to Cash Flow (TTM) 174.34 23.04 23.45
% Owned Institutions -- 0.88 1.40

Dividends

  Company industry sector
Dividend Yield 1.24 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) 0.00 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 4.66 5.38
Sales - 5 Yr. Growth Rate -- 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) -- 2.88 2.98
LT Debt to Equity (MRQ) -- 9.47 11.56
Total Debt to Equity (MRQ) -- 13.43 15.81
Interest Coverage (TTM) -- 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 18.46 15.24
Operating Margin (TTM) 33.89 14.50 7.76
Operating Margin - 5 Yr. Avg. -- 14.42 10.75
Pre-Tax Margin (TTM) 33.89 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -- 14.74 11.17
Net Profit Margin (TTM) 23.12 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -- 11.08 7.47
Effective Tax Rate (TTM) 31.77 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 953,213,833 864,673,366
Net Income/Employee (TTM) 718,922 112,151,384 101,717,513
Receivable Turnover (TTM) -- 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) -- 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.42 11.00
Return on Assets - 5 Yr. Avg. -- 13.00 12.43
Return on Investment (TTM) -- 14.86 14.46
Return on Investment - 5 Yr. Avg. -- 17.00 16.28
Return on Equity (TTM) -- 16.28 16.05
Return on Equity - 5 Yr. Avg. -- 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -2.64 99 25
13 Week -6.52 -7.86 99 37
26 Week -11.71 -17.56 99 30
52 Week -17.27 -26.91 99 12
YTD -11.53 -25.96 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.22%
# of Holders: 21
Total Shares Held: 9,506,931
3 Mo. Net Change: 131,236
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 6
# Reduced Positions: 4
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.